Segment Information - Research and development expenses disaggregated by nature (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Segment Information | ||||
| Total R&D expense | $ 67,407 | $ 62,931 | $ 207,950 | $ 169,741 |
| Single reportable segment | ||||
| Segment Information | ||||
| Personnel | 18,272 | 14,455 | 49,726 | 42,184 |
| Laboratory supplies | 2,138 | 1,057 | 6,188 | 4,769 |
| Facility | 1,422 | 1,410 | 3,540 | 4,214 |
| Product development | 38,401 | 42,371 | 130,304 | 108,073 |
| Other expenses | 7,174 | 3,638 | 18,192 | 10,501 |
| Total R&D expense | $ 67,407 | $ 62,931 | $ 207,950 | $ 169,741 |
| X | ||||||||||
- Definition Facility expense fees incurred during the period. No definition available.
|
| X | ||||||||||
- Definition Product development expenses including but not limited to clinical investigator site fees, external trial monitoring costs, data accumulation costs, contracted research and outside clinical drug product manufacturing. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense associated with supplies that were used during the current accounting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|